Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Find the Mysteries of Effective Objective Setting: Transforming Dreams into Feasible Targets - 2Key takeaways from Sen. Bill Cassidy's interview on 'Face the Nation' with Margaret Brennan
- 3The cheap health insurance promoted by Trump officials has this catch
- 43D Printers for Specialists
- 5Vote in favor of Your Number one Cake Type
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Brilliant and Gleaming: Excellence and Skincare Practices
- New dinosaur tracks in Italy illustrate herds moving in unison
- The most effective method to Distinguish the Best Material Organization in Your Space
- Vote in favor of your Favored kind of pasta
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
- Norovirus infections increase significantly, with positive test rates reaching 14%
- Figure out How to Track and Anticipate Future Cd Rates
- 5 Home EV Chargers for Proficient and Solid Charging
